首页 正文

Cynaropicrin inhibits pancreatic cancer cell viability and disrupts cellular redox homeostasis

{{output}}
Pancreatic cancer accounts for approximately 8% of all cancer-related deaths. The compound cynaropicrin (CNP) has been investigated recently in several cancer models and has been shown to decrease cell viability. We used sulforhodamine B and trypan blue assays... ...